The global burden of IPF is expected to rise, due to the rapidly aging population of Asia Pacific region, with South Korea, in particular, having the highest incidence and prevalence rates of IPF.
Novotech Acquires US-based Drug Development Consulting Firm, CBR International - Expands Drug…
Novotech, the leading Asia Pacific centered biotech CRO today announced the acquisition of CBR In
Read more